Skip to content

Ketamine for PTSD: all studies

Page 3 of 12: studies 21 to 30 of 116, newest first. Back to the ketamine for PTSD overview

Research

Combining DNA methylation features and clinical characteristics predicts ketamine treatment response for PTSD.

iScience January 16, 2026 Amir Valizadeh, John D Roache, Xinyu Zhang et al. 2 citations

Post-traumatic stress disorder (PTSD) exhibits extensive clinical and biological variability, making treatment challenging. The Consortium to Alleviate PTSD (CAP)-ketamine trial, the largest randomized study of ketamine for PTSD, found no overall benefit of ketamine over placebo, underscoring the necessity to identify responsive subgroups. Using pre-treatment blood DNA methylation profiles and...

Blunted arginine vasopressin secretion in individuals experiencing a major depressive episode with comorbid post-traumatic stress disorder: Results from an exploratory study using copeptin as a surrogate marker.

Journal of Neuroendocrinology 2026 Hiroe Hu, Yoojin Lee, Alaina N Tillman et al. 1 citation

Arginine vasopressin (AVP) modulates stress responsivity and social-affective behaviors, but its role in mood and trauma-related disorders remains poorly defined due to challenges in peripheral measurement. This study used copeptin, a stable, reliable, and well-validated surrogate marker of AVP secretion, to assess vasopressinergic function in a transdiagnostic sample of individuals...

A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder

Current Treatment Options in Psychiatry December 26, 2025 Manasicha P. Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon et al.

Purpose A systematic review was conducted to synthesize the efficacy, safety, and tolerability of psychedelics including ketamine, MDMA, ayahuasca, LSD, DMT, ibogaine, and psilocybin in the treatment of PTSD. Recent Findings Among 5,155 studies identified, 42 studies met criteria and were included in our systematic review. Ketamine consistently produced rapid symptom improvement that attenuated...

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder ( PTSD ): A Systematic Review

Acta Psychiatrica Scandinavica December 1, 2025 Liyang Yin, A. Imamog ̄lu, Gia Han Le et al. 3 citations

ABSTRACT Introduction Posttraumatic stress disorder (PTSD) is a mental disorder resulting from exposure to traumatic events. Evidence suggests that ketamine may be efficacious in treating PTSD, however, ketamine's mechanisms in treating PTSD remain unclear. Herein, this review aims to evaluate the clinical outcomes of ketamine treatment in persons with PTSD and investigate the possible...

DOI: 10.1111/acps.70053 (opens in new tab) Ketamine Posttraumatic stress Psychological intervention Anesthesia +1

Ketamine-Assisted Psychotherapy for Treatment- Resistant Depression with Comorbid Post-Traumatic Stress Disorder in Veterans

Insight the psychological dimensions of society November 19, 2025 O. Orlov Aleksey, V. Zaika, O. Fitkalo

The aim of the study was to evaluate the practice of using ketamine-assisted psychotherapy (KAT) in accordance with international clinical guidelines at the State Institution "Center for Mental Health and Veterans' Rehabilitation 'Lisova Polyana' of the Ministry of Health of Ukraine" (Ukraine).Adapting the international clinical guidelines on ketamine therapy for treatmentresistant depression...

Esketamine attenuates post-traumatic stress disorder via suppressing neuroinflammation and abnormal myelination.

Neurochemistry International November 19, 2025 Zhaoliang Gu, Ruixue Song, Guoqiang Liu et al. 3 citations

Post-traumatic stress disorder (PTSD) is a chronic psychological disorder that is induced by traumatic events. The pathophysiological mechanism of PTSD involves complex neurobiological processes. However, the underlying mechanism is not clear, leading to lack of effective therapeutic interventions. Mice were exposed to the electric foot shocks using the contextual fear memory paradigm. A...

DOI: 10.1016/j.neuint.2025.106089 (opens in new tab) Full text (opens in new tab) Fear memory Myelination Neuroinflammation Esketamine For PTSD +1

Ketamine Assisted EMDR Therapy™ for PTSD: investigating the synergistic effects of pharmacotherapy and psychotherapy

European Journal of Psychotraumatology November 4, 2025 Michele Topel, Donald S. Ciccone 2 citations

Background: Posttraumatic stress disorder (PTSD) is associated with maladaptive memory reconsolidation and overgeneralized fear responses. EMDR therapy promotes trauma reprocessing by activating the brain's intrinsic memory reconsolidation mechanism, facilitating memory updating, and abandoning outdated emotional schemas. Ketamine may also facilitate adaptive updating of traumatic memory due to...

DOI: 10.1080/20008066.2025.2572861 (opens in new tab) Ketamine Memory consolidation Clinical psychology Psychotherapist +6

Epigenetic aging and DNA methylation biomarker changes following ketamine treatment in patients with MDD and PTSD: a pilot study.

Translational Psychiatry October 31, 2025 Kristin L Dawson, Athena May Jean M. Carangan, Jessica Klunder et al. 2 citations

Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are debilitating psychiatric conditions associated with poor health outcomes similarly observed in non-pathological aging. Ketamine is a dissociative anesthetic and NMDA receptor antagonist with demonstrated rapid reduction in symptoms associated with Treatment Resistant Depression (TRD) and PTSD. Ketamine's effects on...

Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover study

BJPsych Open October 1, 2025 Ben Beaglehole, Paul Glue, Shona Neehoff et al. 5 citations

We provide preliminary support for the efficacy and tolerability of i.m. ketamine in a community sample of individuals with PTSD. Further work is required to establish the optimal dosing regimen and longer-term role of ketamine in treatment of PTSD, but our findings are encouraging given the well-known of treatments in this area.

Time‐Dependent Therapeutic Effect of S ‐Ketamine on PTSD Mediated by VTA‐OFC Dopaminergic Neurocircuit

Advanced Science September 25, 2025 Ye Wang, Lei Liu, Jinghao Wang et al. 2 citations

Current pharmacotherapies for post-traumatic stress disorder (PTSD) are limited by delayed onset and side effects. Despite ketamine exhibiting rapid relief of the core symptoms of PTSD, its clinical efficacy varies considerably depending on the timing of drug delivery. However, the underlying mechanism remains unclear. In this study, the therapeutic effects of early (day 1) and late (day 7)...

DOI: 10.1002/advs.202500805 (opens in new tab) Mechanism biology Therapeutic effect Therapeutic approach Drug +4